Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Thera continues to post on cancer on Linkedin

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Sep 23, 2022 5:53pm

96 Views

Post# 34983271

RE:RE:Thera continues to post on cancer on Linkedin

Thera was the only green in my portfolio today

SPCEO1 wrote: You asked for the stock to be up a little for once and the market delviered! It was actually up a very little amount for the week as well even though the the average stock was down 4.6% and the Biotech index was down 8%. Sometimes it helps to be overlooked by most investors and not be part of any major ETF's! Hope you are feeling well - enjoy your weekend!

jfm1330 wrote: Again. It does not look like a company seeing a brick wall coming in phase Ib. Add to that the Cantor conference to which they will participate. That being said, I would like to see the SP go up just a little bit.

https://www.linkedin.com/feed/update/urn:li:activity:6979094041627922432/